MIRA Pharmaceuticals, Inc. (MIRA)

NASDAQ: MIRA · Real-Time Price · USD

0.775528

-0.0126 (-1.60%)

Aug 25, 2026, 3:25 PM EDT - Market open

MIRA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.61	6.35	2.83	4.6	0.35	2.81
Short-Term Investments	4.5	4.68	-	-	-	-
Cash & Short-Term Investments	8.11	11.03	2.83	4.6	0.35	2.81
Cash Growth	1010.70%	289.35%	-38.45%	1211.36%	-87.51%	80379.86%
Other Receivables	-	-	-	0.01	-	-
Receivables	-	-	-	0.01	-	-
Prepaid Expenses	0.05	0.03	0.05	0.24	-	-
Other Current Assets	-	-	-	-	0.14	0.1
Total Current Assets	8.17	11.06	2.89	4.86	0.49	2.91
Property, Plant & Equipment	-	-	-	0.01	0.36	-
Long-Term Accounts Receivable	-	-	-	0.07	-	-
Other Long-Term Assets	0.04	0.04	0.04	-	-	0.45
Total Assets	8.2	11.09	2.92	4.93	0.86	3.36

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.04	0.13	0.72	0.54	0.91	0.78
Accrued Expenses	-	-	-	0.01	0.06	0.02
Short-Term Debt	-	0.57	-	-	0.13	0.29
Current Portion of Leases	-	-	-	0.01	0.27	-
Total Current Liabilities	0.04	0.7	0.72	0.56	1.37	1.09
Long-Term Leases	-	-	-	-	0.08	-
Total Liabilities	0.04	0.7	0.72	0.56	1.45	1.09

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-In Capital	50.1	49.97	31.34	25.66	8.7	4.5
Retained Earnings	-41.94	-39.58	-29.14	-21.29	-9.3	-2.24
Shareholders' Equity	8.16	10.39	2.2	4.37	-0.6	2.26
Total Liabilities & Equity	8.2	11.09	2.92	4.93	0.86	3.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0.57	-	0.01	0.49	0.29
Net Cash (Debt)	8.11	10.46	2.83	4.6	-0.14	2.52
Net Cash Growth	1010.70%	269.13%	-38.38%	-	-	-
Net Cash Per Share	0.23	0.44	0.18	0.33	-0.01	0.20
Filing Date Shares Outstanding	42.02	42.02	16.81	14.78	13.31	12.67
Total Common Shares Outstanding	42.02	41.94	16.56	14.78	13.31	12.67
Working Capital	8.13	10.36	2.16	4.3	-0.88	1.82
Book Value Per Share	0.19	0.25	0.13	0.30	-0.04	0.18
Tangible Book Value	8.16	10.39	2.2	4.37	-0.6	2.26
Tangible Book Value Per Share	0.19	0.25	0.13	0.30	-0.04	0.18

SEC Filings: 10-K · 10-Q